Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| COGNITION THERAPEUTICS INCCGTX · Entity 6792 | Director | June 17, 2026 | June 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
COGNITION THERAPEUTICS INC
Report date June 17, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 111,461 |
Reported balance
After 2026-06-17 transaction · row 1
1 source rowRow 1 · 2026-06-17 · Grant · Acquired 25,000 · Balance 111,461 F1: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 17, 2026 Filed Jun 22, 2026 21:14 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-076472 · tm2618497-2_4seq1.xml · nonDerivative · entry 1 Wallace Peggy · CIK 0001876466 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,461 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 17, 2027 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date. Read SEC document |
| June 18, 2025 Filed Jun 23, 2025 23:21 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantCommon Stock | 34,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-012081 · form4.xml · nonDerivative · entry 1 Wallace Peggy · CIK 0001876466 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,461 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 18, 2026 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 22:47 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantStock Option (right to buy) · Derivative | 8,500 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0001062993-24-012414 · form4.xml · derivative · entry 2 Wallace Peggy · CIK 0001876466 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,500 Underlying: Common Stock · 8,500 shares Expires 2034-06-07 F2 · derivative.exercise_date: The option vests in full on the earlier of (i) June 7, 2025 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date. Read SEC document |
| June 07, 2024 Filed Jun 11, 2024 22:47 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantCommon Stock | 8,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-24-012414 · form4.xml · nonDerivative · entry 1 Wallace Peggy · CIK 0001876466 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,461 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 7, 2025 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 21:38 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantStock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $2.77 | $0.00 |
DisclosureSEC source: 0001062993-23-013440 · form4.xml · derivative · entry 2 Wallace Peggy · CIK 0001876466 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires 2033-06-09 F2 · derivative.exercise_date: The option vests in full on the earlier of (i) June 9, 2024 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date. Read SEC document |
| June 09, 2023 Filed Jun 13, 2023 21:38 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantCommon Stock | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-013440 · form4.xml · nonDerivative · entry 1 Wallace Peggy · CIK 0001876466 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,961 F1 · shares: Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on the earlier of (i) June 9, 2024 or (ii) on the date of the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continuous service as a director as of the applicable vesting date. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 13:30 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | PurchaseCommon Stock | 12,500 | $1.20 | $15,000.00 |
DisclosureSEC source: 0001062993-22-022242 · form4.xml · nonDerivative · entry 1 Wallace Peggy · CIK 0001876466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,961 Read SEC document |
| September 27, 2022 Filed Sep 29, 2022 20:01 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | OtherCommon Stock | 22,461 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-020049 · form4.xml · nonDerivative · entry 1 Wallace Peggy · CIK 0001876466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,461 F1 · shares: Represents shares of common stock distributed to the Reporting Person from Golden Seeds Cognition Therapeutics, LLC for no consideration. Read SEC document |
| June 10, 2022 Filed Jun 13, 2022 20:47 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantStock Option (right to buy) · Derivative | 8,335 | $0.00 Strike: $1.98 | $0.00 |
DisclosureSEC source: 0001062993-22-014801 · form4.xml · derivative · entry 1 Wallace Peggy · CIK 0001876466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,335 Underlying: Common Stock · 8,335 shares Expires 2032-06-10 F1 · derivative.exercise_date: The option vests on June 10, 2023, subject to the Reporting Person's continued service through the vesting date. Read SEC document |
| June 10, 2022 Filed Jun 23, 2022 20:07 UTC Amendment | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | GrantStock Option (Right to Buy) · Derivative | 8,335 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0001062993-22-015359 · form4a.xml · derivative · entry 1 Wallace Peggy · CIK 0001876466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,335 Underlying: Common Stock · 8,335 shares Expires 2032-06-10 F1 · derivative.exercise_price: This amendment is being filed solely for the purpose of correcting a scrivener's error in this item. The correct exercise price is "$1.92" as shown herein, and not "$1.98" as was inadvertently entered in the original filing. F2 · derivative.exercise_date: The option vests on June 10, 2023, subject to the Reporting Person's continued service through the vesting date. Read SEC document |
| October 13, 2021 Filed Oct 26, 2021 00:18 UTC | COGNITION THERAPEUTICS INC CGTX · Entity 6792 | PurchaseCommon Stock | 3,000 | $12.00 | $36,000.00 |
DisclosureSEC source: 0001882178-21-000036 · edgar.xml · nonDerivative · entry 1 Wallace Peggy · CIK 0001876466 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.